![]() Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. | ![]() Intersect ENT Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company. | ||
Founding Date | Founding Date 2000 | Founding Date 2002 | Founding Date 2003 |
Type | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations Morrisville, US HQ Oslo, NO Swindon, GB | Locations København, DK HQ Cary, US Cary, US | Locations Menlo Park, US HQ |
Employees | Employees 2048% decrease | Employees 54 | Employees 4337% increase |
Financial | |||
Revenue (est.) | Revenue (est.) $78.2m (FY, 2024) | Revenue (est.) kr39.5m (FY, 2018) | Revenue (est.) $106.7m (FY, 2021) |
Cost of goods | Cost of goods $7.2m (FY, 2024) | Cost of goods kr7.9m (FY, 2018) | Cost of goods $30m (FY, 2021) |
Gross profit | Gross profit $71m (FY, 2024) | Gross profit kr31.6m (FY, 2018) | Gross profit $76.7m (FY, 2021) |
Net income | Net income ($21.5m) (FY, 2024) | Net income (kr5.3m) (FY, 2018) | Net income ($159.6m) (FY, 2021) |
Operating ⚠ | |||
Patents (US) | Patents (US) 43 (Jun, 2017) | Patents (US) N/A | Patents (US) 30 (FY, 2016) |
Trademarks (US) | Trademarks (US) 3 (Jun, 2017) | Trademarks (US) N/A | Trademarks (US) 4 (FY, 2016) |
Funding | |||
Total funding raised | Total funding raised $ 120.5m | Total funding raised $ 60m | Total funding raised $ 102.9m |

Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View company
Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company.
View company